alfuzosin and moxifloxacin

alfuzosin has been researched along with moxifloxacin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Armstrong, P; Borer, J	1
Beaufils, P; Cabanis, MJ; Extramiana, F; Leenhardt, A; Maison-Blanche, P; Ortemann-Renon, C	1

Reviews

1 review(s) available for alfuzosin and moxifloxacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for alfuzosin and moxifloxacin

Article	Year
Clinical assessment of drug-induced QT prolongation in association with heart rate changes. Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:4 Topics: Adrenergic alpha-Antagonists; Adult; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Predictive Value of Tests; Quinazolines; Quinolines; Reproducibility of Results; Treatment Outcome	2005

Article

Year

Clinical assessment of drug-induced QT prolongation in association with heart rate changes.

Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:4

Topics: Adrenergic alpha-Antagonists; Adult; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Predictive Value of Tests; Quinazolines; Quinolines; Reproducibility of Results; Treatment Outcome

2005

Other Studies

3 other study(ies) available for alfuzosin and moxifloxacin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003. Circulation, 2003, Jun-17, Volume: 107, Issue:23 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adolescent; Adult; Advisory Committees; Anti-Infective Agents; Aza Compounds; Cardiovascular Agents; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Approval; Electrocardiography; Fluoroquinolones; Humans; Imidazoles; Impotence, Vasculogenic; Male; Middle Aged; Moxifloxacin; Phosphoric Diester Hydrolases; Piperazines; Prostatic Hyperplasia; Quinazolines; Quinolines; Risk Assessment; Sulfones; Triazines; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride	2003